Association between preservation injury and early rejection in clinical liver transplantation: fact or myth?
Katz
E
E
Department of Surgery, Mount Sinai Medical Center, New York, New York 10029.
Mor
E
E
Patel
T
T
Theise
N
N
Emre
S
S
Schwartz
M E
ME
Miller
C M
CM
D000241:Adenosine; D000493:Allopurinol; D001706:Biopsy; D005978:Glutathione; D006084:Graft Rejection; D006801:Humans; D006982:Hypertonic Solutions; D007328:Insulin; D016031:Liver Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009926:Organ Preservation; D019188:Organ Preservation Solutions; D011887:Raffinose; D015427:Reperfusion Injury; D012189:Retrospective Studies; D012996:Solutions; D014184:Transplantation, Homologous
C037096:Euro-Collins' solution; D006982:Hypertonic Solutions; D007328:Insulin; D016853:Muromonab-CD3; D019188:Organ Preservation Solutions; D012996:Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose